Fox Chase Supports Virtual Walk to End Bladder Cancer

PHILADEPHIA (April 30, 2021) – Fox Chase Cancer Center is pleased to announce its support for the Bladder Cancer Advocacy Network’s (BCAN) virtual Walk to End Bladder Cancer, which will be held on Saturday, May 1, 2021, at 11 a.m.

Since the event is virtual, participants can walk from their own location and are encouraged to post pictures on social media to spread awareness. BCAN will be also have live broadcasts on their own social media channels throughout the event.

Link to

Fox Chase’s team will be led by Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician and an Ambassador of the 2021 BCAN Walk to End Bladder Cancer.

“This year’s theme is ‘No one walks alone,’ and it couldn’t be more true. A diagnosis of bladder cancer is a personal journey, but not one that is taken without the support of family, friends, healthcare providers, and the BCAN organization,” said Tetzlaff.

“Our Fox Chase Cancer Center Team is participating in the Virtual Walk to End Bladder Cancer to champion for our patients and their families, to honor those we’ve lost, and to raise funds to support BCAN’s patient education and advocacy efforts, as well as for research to find new treatments and hopefully a cure for bladder cancer.”

For more information about the virtual Walk to End Bladder Cancer and to register to join the Fox Chase team or make a donation, visit the event page.

BCAN is the only national advocacy organization devoted to advancing bladder cancer research and supporting those impacted by the disease. Each year, BCAN provides thousands of patients, caregivers, and the medical community with the educational resources and support services they need to navigate their bladder cancer journey.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text